Oramed Pharmaceuticals Inc.
ORMP
$2.12
-$0.05-2.30%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -35.88% | -26.02% | -12.41% | -18.70% | 1.69% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -10.88% | 24.55% | 140.41% | -28.83% | -30.69% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -35.39% | -25.76% | -11.91% | -18.74% | 1.52% |
|
|||||
Total Current Assets | -35.39% | -25.76% | -11.91% | -18.74% | 1.52% |
Net Property, Plant & Equipment | 14.73% | -29.01% | -29.04% | -28.80% | -25.52% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 14,966.67% | 15,233.33% | 0.00% | 0.00% | -9.09% |
Total Assets | -12.23% | -27.55% | -29.60% | -28.50% | 17.85% |
|
|||||
Total Accounts Payable | -79.47% | -59.83% | 43.19% | 95.04% | 320.65% |
Total Accrued Expenses | -- | 101,300.00% | 6.72% | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 5.60% | -28.74% | -19.10% | -3.19% | 5.93% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -1.07% | -83.63% | -89.32% | -93.25% | 249.86% |
|
|||||
Total Current Liabilities | -1.07% | -83.63% | -89.32% | -93.25% | 249.86% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 174.58% | -55.88% | -54.39% | -52.19% | -51.64% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -8.29% | -50.45% | -0.29% | 0.02% | -0.10% |
Total Liabilities | 0.40% | -79.84% | -82.78% | -88.44% | 42.59% |
|
|||||
Common Stock & APIC | 0.50% | 0.75% | 0.47% | 0.89% | 1.46% |
Retained Earnings | -16.46% | -18.10% | -12.10% | 2.61% | 12.44% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -12.73% | -15.50% | -10.72% | 4.90% | 16.84% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -12.73% | -15.50% | -10.72% | 4.90% | 16.84% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -3.84% | 0.00% | 1.08% | -1.88% | -2.24% |
Total Equity | -12.81% | -15.58% | -10.77% | 4.92% | 16.93% |
|